Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
157,5 INR | +0,37% |
|
+2,29% | +13,41% |
14/05 | PIRAMAL PHARMA LIMITED : giudizio positivo da Jefferies & Co. | ZM |
13/05 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
Attività
Numero di dipendenti: 6 295
Vendite per attività
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Global Pharma
87,0
%
| 22 356 | 72,2 % | 61 581 | 87,0 % | +175,45% |
Over the Counter Products
11,6
%
| 7 420 | 24,0 % | 8 188 | 11,6 % | +10,35% |
Distribution Fees
0,8
%
| - | - | 556 | 0,8 % | - |
Scrap
0,5
%
| - | - | 323 | 0,5 % | - |
Others
0,2
%
| - | - | 169 | 0,2 % | - |
Vendite per regione
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
International
79,6
%
| - | - | 56 371 | 79,6 % | - |
India
20,4
%
| 30 950 | 100,0 % | 14 445 | 20,4 % | -53,33% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Peter DeYoung
CEO | Chief Executive Officer | 46 | 04/03/20 |
Vivek Valsaraj
PSD | President | 51 | 10/06/20 |
Vinay Agrawal
COO | Chief Operating Officer | 60 | 05/04/20 |
Gagan Borana
IRC | Investor Relations Contact | - | - |
Prasanth M. S.
SAM | Sales & Marketing | 51 | 10/06/20 |
Vikram Duggal
HRO | Human Resources Officer | 50 | 08/01/20 |
Sameer Penkar
SAM | Sales & Marketing | - | 10/06/20 |
Corporate Secretary | - | 04/03/20 | |
Rashida Najmi
PRN | Corporate Officer/Principal | 58 | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chairman | 43 | 04/01/21 | |
Neeraj Bharadwaj
BRD | Director/Board Member | 55 | - |
Director/Board Member | 76 | 09/02/21 | |
Director/Board Member | 51 | 30/03/22 | |
Vibha Paul Rishi
BRD | Director/Board Member | 64 | 29/09/22 |
Director/Board Member | 65 | 09/02/21 | |
Peter DeYoung
CEO | Chief Executive Officer | 46 | 04/03/20 |
Vivek Valsaraj
PSD | President | 51 | 10/06/20 |
Peter Stevenson
BRD | Director/Board Member | - | 30/03/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 1 320 816 324 | 354 235 407 ( 26,82 %) | 0 | 26,82 % |
Coordinate società
Piramal Pharma Ltd.
507, Skyline Wealth Space, 5th Floor C2 Wing, Skyline Oasis Complex
400086, Mumbai
+91 22 3802 3000
http://www.piramal.com/businesses/piramal-pharma/![Indirizzo Piramal Pharma Limited(PPLPHARMA)](https://cdn.zonebourse.com/static/address/145512665.png)
Settore
Vendite per attività
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Fatturato trimestrale - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
+13,41% | 2,49 Mrd | |
+55,95% | 811 Mrd | |
+43,62% | 640 Mrd | |
-6,98% | 353 Mrd | |
+19,08% | 333 Mrd | |
+9,05% | 302 Mrd | |
+16,30% | 246 Mrd | |
+2,41% | 225 Mrd | |
+12,47% | 218 Mrd | |
+8,91% | 168 Mrd |
- Borsa valori
- Azioni
- Azione PPLPHARMA
- Società Piramal Pharma Limited